Venture Capital: Nested Therapeutics Raises $90M Series ‘A’ Led By Goldman Sachs Asset Management
Nested Therapeutics, which is building a next-generation precision medicine platform for hard-to-treat cancers, announced its emergence from stealth with a $90 million Series A round led by Goldman Sachs Asset Management with participation from Foresite Capital, Cowen Healthcare Investments, Section 32, and Avidity Partners. Nested was founded by Versant Ventures.
